Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
6.61
+2.56 (63.21%)
At close: Aug 13, 2025, 4:00 PM
6.70
+0.09 (1.34%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $44.31 million as of August 13, 2025. Its market cap has decreased by -81.02% in one year.
Market Cap
44.31M
Enterprise Value
-11.73M
1-Year Change
-81.02%
Ranking
Category
Stock Price
$6.61
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $44.31M, a decrease of -95.86%. That is a compound annual growth rate of -46.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 27.15M | -61.65% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.74B |
| Johnson & Johnson | 419.03B |
| AbbVie | 355.31B |
| UnitedHealth Group | 244.59B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.34B |
| Novo Nordisk | 223.00B |